NORDIC NANOVECTOR NK 0,20
NORDIC NANOVECTOR NK 0,20
Share · NO0010597883 · A1H64K (XOSL)
Overview
No Price
Closing Price XOSL 09.12.2025: 4,12 NOK
19.12.2025 07:03
Current Prices from NORDIC NANOVECTOR NK 0,20
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
8NN.F
EUR
19.12.2025 07:03
0,36 EUR
0,004 EUR
+1,13 %
XDQU: Quotrix
Quotrix
TMASAN83.DUSD
EUR
19.12.2025 06:27
0,36 EUR
0,010 EUR
+2,69 %
XDUS: Düsseldorf
Düsseldorf
TMASAN83.DUSB
EUR
18.12.2025 07:11
0,36 EUR
0,01 EUR
+3,80 %
XOSL: OSLO BORS
OSLO BORS
TRMED.OL
NOK
09.12.2025 08:26
4,12 NOK
0,010 NOK
+0,24 %
Share Float & Liquidity
Free Float 32,56 %
Shares Float 115,28 M
Shares Outstanding 354,08 M
Company Profile for NORDIC NANOVECTOR NK 0,20 Share
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. The company was founded in 2017 and is headquartered in Oslo, Norway.
Get up to date insights from finAgent about NORDIC NANOVECTOR NK 0,20

Company Data

Name NORDIC NANOVECTOR NK 0,20
Company Thor Medical ASA
Website https://www.thormedical.no
Primary Exchange XOSL OSLO BORS
WKN A1H64K
ISIN NO0010597883
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jasper Kurth
Market Capitalization 2 Mrd.
Country Norway
Currency EUR
Employees 0,0 T
Address Karenslyst allé 9C, 0278 Oslo
IPO Date 2015-03-23

Ticker Symbols

Name Symbol
OSLO BORS TRMED.OL
Düsseldorf TMASAN83.DUSB
Frankfurt 8NN.F
Quotrix TMASAN83.DUSD
More Shares
Investors who hold NORDIC NANOVECTOR NK 0,20 also have the following shares in their portfolio:
BILIBILI 19/26 CV
BILIBILI 19/26 CV Bond
ERSTE GR.BK. 22/26 MTN
ERSTE GR.BK. 22/26 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025